Xenon Pharmaceuticals Commences Underwritten Public Offering Of $225M Of Its Common Shares

Xenon Pharmaceuticals Inc. -0.83% Pre

Xenon Pharmaceuticals Inc.

XENE

38.29

38.29

-0.83%

0.00% Pre

In addition, Xenon intends to grant the underwriters an option for a period of 30 days to purchase up to an additional $33.75 million of common shares at the public offering price

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via